Published in J Gen Intern Med on July 01, 2002
Factors That Influence Compliance With Disease-Modifying Therapy in Multiple Sclerosis | NCT00223457
Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) (2008) 12.08
New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care (2009) 3.73
The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review. Int J Clin Pract (2007) 2.51
Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch Intern Med (2005) 2.28
Barriers to and determinants of medication adherence in hypertension management: perspective of the cohort study of medication adherence among older adults. Med Clin North Am (2009) 2.10
A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline. Neurology (2008) 1.91
Family influences on heart failure self-care and outcomes. J Cardiovasc Nurs (2008) 1.88
Effects of enhanced depression treatment on diabetes self-care. Ann Fam Med (2006) 1.76
Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis. J Gen Intern Med (2011) 1.75
Factors associated with adherence to anti-hypertensive treatment in Pakistan. PLoS One (2007) 1.60
The association of depression with adherence to antihypertensive medications: a systematic review. J Hypertens (2010) 1.54
The association of emotional well-being and marital status with treatment adherence among patients with hypertension. J Behav Med (2008) 1.54
Integration of depression and hypertension treatment: a pilot, randomized controlled trial. Ann Fam Med (2008) 1.51
Provider communication effects medication adherence in hypertensive African Americans. Patient Educ Couns (2008) 1.51
Determinants of medication adherence to antihypertensive medications among a Chinese population using Morisky Medication Adherence Scale. PLoS One (2013) 1.37
Racial differences in medication adherence: A cross-sectional study of Medicare enrollees. Am J Geriatr Pharmacother (2010) 1.30
Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention. Br J Clin Pharmacol (2005) 1.29
Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism. Patient Prefer Adherence (2010) 1.26
Health-related quality of life and antihypertensive medication adherence among older adults. Age Ageing (2010) 1.17
Predictors of adherence in the Women's Health Initiative Calcium and Vitamin D Trial. Behav Med (2009) 1.16
Risk factors for nonadherence to warfarin: results from the IN-RANGE study. Pharmacoepidemiol Drug Saf (2008) 1.15
Low medication adherence and hypertension control among adults with CKD: data from the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. Am J Kidney Dis (2010) 1.15
Factors associated with treatment compliance in hypertension in southwest Nigeria. J Health Popul Nutr (2011) 1.13
Association of depression with antihypertensive medication adherence in older adults: cross-sectional and longitudinal findings from CoSMO. Ann Behav Med (2010) 1.12
Prevalence and correlates of low medication adherence in apparent treatment-resistant hypertension. J Clin Hypertens (Greenwich) (2012) 1.10
A review of studies of adherence with antihypertensive drugs using prescription databases. Ther Clin Risk Manag (2005) 1.07
Persistence and determinants of statin therapy among middle-aged patients free of cardiovascular disease. Eur J Clin Pharmacol (2005) 1.05
Relationship of treatment satisfaction to medication adherence: findings from a cross-sectional survey among hypertensive patients in Palestine. Health Qual Life Outcomes (2013) 1.04
Adverse effects of complementary and alternative medicine on antihypertensive medication adherence: findings from the cohort study of medication adherence among older adults. J Am Geriatr Soc (2010) 1.04
Symptoms of depression and anxiety and adherence to antihypertensive medication. Am J Hypertens (2012) 1.03
Hypertension and depression: coexisting barriers to medication adherence. J Clin Hypertens (Greenwich) (2010) 1.02
Sex differences in barriers to antihypertensive medication adherence: findings from the cohort study of medication adherence among older adults. J Am Geriatr Soc (2013) 0.97
Comparison of diet quality, physical activity and biochemical values of older adults either reporting or not reporting use of lipid-lowering medication. J Nutr Health Aging (2010) 0.97
Prevalence of psychological distress in elderly hypertension patients in primary care. Neth Heart J (2014) 0.96
Regimen complexity and medication nonadherence in elderly patients. Ther Clin Risk Manag (2009) 0.96
Taking less than prescribed: medication nonadherence and provider-patient relationships in lower-income, rural minority adults with hypertension. J Clin Hypertens (Greenwich) (2010) 0.96
Kidney function and long-term medication adherence after myocardial infarction in the elderly. Clin J Am Soc Nephrol (2011) 0.95
Patient attitudinal and behavioral factors associated with warfarin non-adherence at outpatient anticoagulation clinics. Int J Behav Med (2010) 0.90
Pilot trial of a licensed practical nurse intervention for hypertension and depression. Fam Med (2013) 0.89
Antihypertensive medication adherence in cancer survivors and its affecting factors: results of a Korean population-based study. Support Care Cancer (2010) 0.89
Cohort study of medication adherence in older adults (CoSMO): extended effects of Hurricane Katrina on medication adherence among older adults. Am J Med Sci (2008) 0.89
Do psychological attributes matter for adherence to antihypertensive medication? The Finnish Public Sector Cohort Study. J Hypertens (2008) 0.89
Life events, coping, and antihypertensive medication adherence among older adults: the cohort study of medication adherence among older adults. Am J Epidemiol (2012) 0.88
Patient-related barriers to hypertension control in a Nigerian population. Int J Gen Med (2014) 0.87
Prevalence of undiagnosed depression among persons with hypertension and associated risk factors: a cross-sectional study in urban Nepal. PLoS One (2015) 0.85
Factors associated with non-adherence to three hypertension self-management behaviors: preliminary data for a new instrument. J Gen Intern Med (2012) 0.83
Is there a nonadherent subtype of hypertensive patient? A latent class analysis approach. Patient Prefer Adherence (2010) 0.81
The role of depression in medication adherence among heart failure patients. Clin Nurs Res (2013) 0.81
Extent and reasons for nonadherence to antihypertensive, cholesterol, and diabetes medications: the association with depressive symptom burden in a sample of American veterans. Patient Prefer Adherence (2015) 0.80
Adherence to the low-sodium diet plays a role in the interaction between depressive symptoms and prognosis in patients with heart failure. J Cardiovasc Nurs (2011) 0.80
Antihypertensive medication nonadherence in black men: direct and mediating effects of depressive symptoms, psychosocial stressors, and substance use. J Clin Hypertens (Greenwich) (2012) 0.80
The association of smoking with medical treatment adherence in the workforce of a large employer. Patient Prefer Adherence (2014) 0.79
Adherence to Oral Medications for Hypertension and Diabetes in Veterans with Comorbid Airflow Limitation. Ann Am Thorac Soc (2015) 0.78
Patient adherence and preference considerations in managing cardiovascular risk: focus on single pill and amlodipine/atorvastatin fixed combination. Patient Prefer Adherence (2009) 0.78
Depression and ambivalence toward chronic opioid therapy for chronic noncancer pain. Clin J Pain (2012) 0.78
The best of JGIM. J Gen Intern Med (2002) 0.78
Initial persistence with antihypertensive therapies is associated with depression treatment persistence, but not depression. J Clin Hypertens (Greenwich) (2014) 0.78
Adherence to Antihypertensive Therapy. Med Clin North Am (2017) 0.78
Time perspective and medication adherence among individuals with hypertension or diabetes mellitus. Patient Educ Couns (2014) 0.77
Short Form (SF-36) Health Survey measures are associated with decreased adherence among urban African Americans with severe, poorly controlled hypertension. J Clin Hypertens (Greenwich) (2010) 0.77
Predictors of Changes in Medication Adherence in Blacks with Hypertension: Moving Beyond Cross-Sectional Data. Ann Behav Med (2016) 0.77
Beyond inpatient and outpatient care: alternative model for hypertension management. BMC Public Health (2006) 0.77
Breaks in continuity of care and the rural senior transferred for medical care under regionalisation. Int J Integr Care (2003) 0.76
Results from the Trial Using Motivational Interviewing, Positive Affect, and Self-Affirmation in African Americans with Hypertension (TRIUMPH). Ethn Dis (2016) 0.76
Race and Sex Differences in Correlates of Systolic Blood Pressure in Community-Dwelling Older Adults. J Health Dispar Res Pract (2016) 0.75
The B-SMART Appropriate Medication-Use Process: A Guide for Clinicians to Help Patients- Part 1: Barriers, Solutions, and Motivation. Perm J (2009) 0.75
Variations of depression treatment among women with hypertension. Health Care Women Int (2015) 0.75
Selected factors affecting adherence in the pharmacological treatment of arterial hypertension. Patient Prefer Adherence (2017) 0.75
Effects of Physician Communication and Family Hardiness on Patient Medication Regimen Beliefs and Adherence. Gen Med (Los Angel) (2015) 0.75
Psychological morbidity and substance use among patients with hypertension: a hospital-based cross-sectional survey from South West Ethiopia. Int J Ment Health Syst (2017) 0.75
Connection between Depression and Inability to Fill Prescriptions in Rural FQHC Patients with Chronic Disease. Rural Ment Health (2016) 0.75
The place for ACE inhibitors. J Gen Intern Med (2004) 0.75
eHealth in the future of medications management: personalisation, monitoring and adherence. BMC Med (2017) 0.75
Factors associated with antihypertensive medication non-adherence: a systematic review. J Hum Hypertens (2017) 0.75
The Brief Symptom Inventory: an introductory report. Psychol Med (1983) 22.83
The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med (1997) 19.14
Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension (1995) 10.38
Randomised clinical trial of strategies for improving medication compliance in primary hypertension. Lancet (1975) 7.22
The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA (1997) 6.32
Improvement of medication compliance in uncontrolled hypertension. Lancet (1976) 4.84
Recent care of common mental disorders in the United States : prevalence and conformance with evidence-based recommendations. J Gen Intern Med (2000) 4.63
Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med (1998) 4.29
The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med (1990) 4.18
Persistence of use of lipid-lowering medications: a cross-national study. JAMA (1998) 4.15
Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care (1996) 3.70
Health education for hypertensive patients. JAMA (1979) 2.62
Hypertension in a family practice. Can Med Assoc J (1977) 2.36
Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race. Am J Public Health (1996) 2.33
The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens (1997) 2.21
Refractory hypertension. N Engl J Med (1992) 1.97
Treatment for glaucoma: adherence by the elderly. Am J Public Health (1993) 1.90
Medication management of depression in the United States and Ontario. J Gen Intern Med (1998) 1.78
Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol (1995) 1.73
Change in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group (Systoloc Hypertension in the elderly). Arch Intern Med (1996) 1.72
The psychological factors associated with poor compliance with treatment in asthma. Eur Respir J (1995) 1.70
Major depressive disorder in coronary artery disease. Am J Cardiol (1987) 1.69
Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Arch Neurol (1997) 1.66
Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med (1989) 1.65
The patient's view of hypertension and compliance. Am J Prev Med (1992) 1.51
Improving compliance and increasing control of hypertension: needs of special hypertensive populations. Am Heart J (1991) 1.44
Management of patient compliance in the treatment of hypertension. Report of the NHLBI Working Group. Hypertension (1982) 1.35
Patient compliance with antihypertensive medication. Am J Public Health (1980) 1.34
A study of treatment compliance following kidney transplantation. Transplantation (1993) 1.31
Beliefs, social normative influences, and compliance with antihypertensive medication. Am J Prev Med (1988) 1.30
Psychiatric disorders and 15-month mortality in a community sample of older adults. Am J Public Health (1989) 1.29
Compliance and blood pressure control. Hypertension (1988) 1.28
Increased antidepressant use in patients prescribed beta-blockers. JAMA (1986) 1.26
Social desirability and response to perceived situational demands. J Consult Psychol (1961) 1.25
A comparison of somatic complaints among depressed and non-depressed older persons. Gerontologist (1985) 1.10
Maintaining long-term control of blood pressure: the role of improved compliance. Clin Cardiol (1995) 1.08
Recent trends in public knowledge, attitudes, and reported behavior with respect to high blood pressure. Public Health Rep (1982) 1.07
Compliance with antihypertensive treatment in consultation rooms for hypertensive patients. J Hum Hypertens (1993) 1.07
Risk factors for antihypertensive medication refill failure by patients under Medicaid managed care. Clin Ther (1997) 1.07
Identification of the noncompliant hypertensive patient. Prev Med (1980) 1.02
Factors associated with noncompliance of patients taking antihypertensive medications. Hosp Pharm (1995) 0.96
Patient reaction to information and motivation factors in long-term treatment with antihypertensive drugs. Acta Med Scand (1980) 0.95
Doctor-patient communication: some quantitative estimates of the role of cognitive factors in non-compliance. J Hypertens Suppl (1985) 0.93
Subjective bias in reports of poor work adjustment in depressed patients. Acta Psychiatr Scand (1989) 0.92
Continuity of care in hypertension. An important correlate of blood pressure control among aware hypertensives. Arch Intern Med (1988) 0.92
Managing the patient with hard-to-control hypertension. Am Fam Physician (1998) 0.91
Role of health locus of control beliefs and expectations of treatment efficacy in adjustment to cancer. J Pers Soc Psychol (1986) 0.90
Myocardial infarction survivors: age and gender differences in physical health, psychosocial state and regimen adherence. J Adv Nurs (1991) 0.89
High fatality rates of late-life depression associated with cardiovascular disease. J Affect Disord (1985) 0.87
Compliance with antihypertensive treatment. Clin Exp Hypertens (1996) 0.85
Improving compliance among hypertensives: a triage criterion with cost-benefit implications. Med Care (1982) 0.82
Medication nonadherence due to feelings of loss of control in "biological depression". Am J Psychiatry (1985) 0.80
Randomized response technique for estimating alcohol use and noncompliance in hypertensives. J Stud Alcohol (1982) 0.78
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med (2008) 43.36
Variable selection for propensity score models. Am J Epidemiol (2006) 10.68
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet (2009) 10.52
A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol (2005) 8.77
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med (2003) 8.65
Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med (2005) 8.44
Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 8.32
High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology (2009) 7.40
A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol (2005) 7.31
Long-term persistence in use of statin therapy in elderly patients. JAMA (2002) 7.19
Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J (2004) 6.57
Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol (2005) 6.20
A randomized study of how physicians interpret research funding disclosures. N Engl J Med (2012) 5.47
Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA (2012) 5.25
Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 5.13
Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med (2014) 4.99
Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol (2003) 4.95
Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA (2011) 4.73
Self-management education programs in chronic disease: a systematic review and methodological critique of the literature. Arch Intern Med (2004) 4.68
Full coverage for preventive medications after myocardial infarction. N Engl J Med (2011) 4.51
The comparative safety of analgesics in older adults with arthritis. Arch Intern Med (2010) 4.47
Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet (2012) 4.46
Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA (2012) 4.40
New FDA breakthrough-drug category--implications for patients. N Engl J Med (2014) 4.30
Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst (2002) 4.16
HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial. Lancet (2010) 4.07
Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors. N Engl J Med (2002) 4.07
Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses' Health Study. J Am Coll Cardiol (2009) 3.99
A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol (2011) 3.98
Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States. BMJ (2013) 3.88
Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death. JAMA (2010) 3.85
Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. Am J Epidemiol (2007) 3.82
The epidemiology of prescriptions abandoned at the pharmacy. Ann Intern Med (2010) 3.78
The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. Arch Intern Med (2006) 3.64
Burden of changes in pill appearance for patients receiving generic cardiovascular medications after myocardial infarction: cohort and nested case-control studies. Ann Intern Med (2014) 3.62
Effect of smoking on comparative efficacy of antiplatelet agents: systematic review, meta-analysis, and indirect comparison. BMJ (2013) 3.43
The quality of pharmacologic care for vulnerable older patients. Ann Intern Med (2004) 3.34
Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly. Am J Epidemiol (2005) 3.33
The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med (2011) 3.27
Rethinking the use of physicians as hired expert lecturers. Ann Intern Med (2014) 3.22
Blood pressure and risk of developing type 2 diabetes mellitus: the Women's Health Study. Eur Heart J (2007) 3.21
Drug-review deadlines and safety problems. N Engl J Med (2008) 3.16
Variations in pill appearance of antiepileptic drugs and the risk of nonadherence. JAMA Intern Med (2013) 3.13
Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome. Circulation (2009) 3.09
Balancing innovation, access, and profits--market exclusivity for biologics. N Engl J Med (2009) 3.08
Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis. Arthritis Rheum (2006) 3.04
High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy. Circulation (2013) 3.03
Confounding control in healthcare database research: challenges and potential approaches. Med Care (2010) 3.01
Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation (2004) 2.98
University-based science and biotechnology products: defining the boundaries of intellectual property. JAMA (2005) 2.95
Compliance with osteoporosis medications. Arch Intern Med (2005) 2.91
Nonsteroidal anti-inflammatory drug use and acute myocardial infarction. Arch Intern Med (2002) 2.82
Selective prescribing led to overestimation of the benefits of lipid-lowering drugs. J Clin Epidemiol (2006) 2.81
Internet marketing of herbal products. JAMA (2003) 2.77
Economic implications of evidence-based prescribing for hypertension: can better care cost less? JAMA (2004) 2.77
Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study. Am J Epidemiol (2010) 2.74
Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs. Circulation (2003) 2.73
The comparative safety of opioids for nonmalignant pain in older adults. Arch Intern Med (2010) 2.71
Comparative mortality risk of anemia management practices in incident hemodialysis patients. JAMA (2010) 2.71
Sending pharma better signals. Science (2005) 2.69
Identification of individuals with CKD from Medicare claims data: a validation study. Am J Kidney Dis (2005) 2.65
Improved comorbidity adjustment for predicting mortality in Medicare populations. Health Serv Res (2003) 2.65
Characteristics of clinical trials to support approval of orphan vs nonorphan drugs for cancer. JAMA (2011) 2.60
Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. J Am Coll Cardiol (2008) 2.58
Excess weight and the risk of incident coronary heart disease among men and women. Obesity (Silver Spring) (2009) 2.56
Performance of propensity score calibration--a simulation study. Am J Epidemiol (2007) 2.56
Adjusting effect estimates for unmeasured confounding with validation data using propensity score calibration. Am J Epidemiol (2005) 2.55
Practical, legal, and ethical issues in expanded access to investigational drugs. N Engl J Med (2015) 2.53
Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors. N Engl J Med (2004) 2.52
Incorporation of clustering effects for the Wilcoxon rank sum test: a large-sample approach. Biometrics (2003) 2.49
Statin adherence and risk of accidents: a cautionary tale. Circulation (2009) 2.47
Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries. Circulation (2008) 2.42
Evaluating uses of data mining techniques in propensity score estimation: a simulation study. Pharmacoepidemiol Drug Saf (2008) 2.42